Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Antisocial behaviour and conduct disorders in children and young people: recognition and management

Clinical guideline
Reference number: CG158
Published: 27 March 2013
Last updated: 19 April 2017

History

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF 614 KB)

Published:

02 February 2017
Consultation comments and responses (MSWord 28 KB)

Published:

02 February 2017

Stakeholder list updated

Stakeholder list (PDF 47 KB)

Published:

01 February 2017

Background information

CG158 Conduct disorders in children and young people: press release information

Conduct disorders in children and young people: guideline equality impact assessment

Conduct disorders in children and young people: guideline equality impact assessment (PDF 190 KB)

Published:

10 September 2013

Conduct disorders in children and young people: health economic plan, review questions and search strategies

Conduct disorders in children and young people: health economic plan, review questions and search strategies
Conduct disorders in children and young people: economic plan (pre consultation) (PDF 18 KB)

Published:

13 June 2012
Conduct disorders in children and young people: review questions (PDF 299 KB)

Published:

13 June 2012
Conduct disorders in children and young people: search strategies for the identification of health economic evidence (PDF 696 KB)

Published:

13 June 2012
Conduct disorders in children and young people: search strategies for the identification of clinical evidence (PDF 818 KB)

Published:

13 June 2012

Conduct disorders in children and young people: remit

Conduct disorders in children and young people: remit (PDF 17 KB)

Published:

26 March 2010

Conduct disorders in children and young people: scoping workshop, consultation and final scope

Conduct disorders in children and young people: scoping workshop, consultation and final scope
Conduct disorders in children and young people: final scope (PDF 64 KB)

Published:

23 May 2011
Conduct disorders in children and young people: equalities impact assessment (scoping) (PDF 39 KB)

Published:

23 May 2011
Conduct disorders in children and young people: scope consultation comments table with developer's responses (PDF 290 KB)

Published:

23 May 2011
Conduct disorders in children and young people: scoping workshop notes (PDF 46 KB)

Published:

13 January 2011
Conduct disorders in children and young people: scope consultation information
Conduct disorders in children and young people: draft scope for consultation (PDF 46 KB)

Published:

13 January 2011
Conduct disorders in children and young people: scope consultation comments proforma (MSWord 44 KB)

Published:

12 January 2011

Conduct disorders in children and young people: guideline development and consultation

Conduct disorders in children and young people: guideline development and consultation
Conduct disorders in children and young people: consultation comments (PDF 936 KB)

Published:

27 March 2013
Conduct disorders in children and young people: guideline consultation information
Conduct disorders in children and young people: appendices (PDF 2.12 MB)

Published:

16 August 2012
Conduct disorders in children and young people: draft NICE guideline (PDF 379 KB)

Published:

15 August 2012
Conduct disorders in children and young people: draft guidance (PDF 3.18 MB)

Published:

15 August 2012
Conduct disorders in children and young people: confidentiality agreement (MSWord 52 KB)

Published:

15 August 2012
Conduct disorders in children and young people: GDG minutes
Conduct disorders in children and young people: GDG minutes: 2 May 2012 (PDF 90 KB)

Published:

30 May 2012
Conduct disorders in children and young people: GDG minutes: 14 March 2012 (PDF 152 KB)

Published:

30 May 2012
Conduct disorders in children and young people: GDG minutes: 1 February 2012 (PDF 15 KB)

Published:

02 March 2012
Conduct disorders in children and young people: GDG minutes: 7 December 2011 (PDF 32 KB)

Published:

02 March 2012
Conduct disorders in children and young people: GDG minutes: 14 September 2011 (PDF 14 KB)

Published:

02 March 2012
Conduct disorders in children and young people: GDG minutes: 27 July 2011 (PDF 32 KB)

Published:

02 March 2012
Conduct disorders in children and young people: GDG minutes: 27 June 2011 (PDF 33 KB)

Published:

02 March 2012
Conduct disorders in children and young people: GDG minutes: 18 May 2011 (PDF 31 KB)

Published:

02 March 2012
Conduct disorders in children and young people: GDG minutes: 13 April 2011 (PDF 42 KB)

Published:

02 March 2012
Conduct disorders in children and young people: GDG membership list (PDF 43 KB)

Published:

10 February 2012